Showing 621 - 640 results of 1,771 for search '(( i point decrease ) OR ( 10 ((we decrease) OR (((a decrease) OR (mean decrease)))) ))*', query time: 0.34s Refine Results
  1. 621

    Anti-Neoplastic Effects of Annonacin against Renal Cell Carcinoma by Munusamy, Shankar

    Published 2016
    “…M annonacin treated vs. 7% of cells in G1 phase in control group. In addition, a dose-dependent decrease in the phosphorylation of p70S6 kinase (a downstream target of mTOR) was observed with annonacin treatment at both 24 and 48 h end-points. …”
    Get full text
    Get full text
  2. 622
  3. 623
  4. 624
  5. 625

    Trends in prevalence of depression and anxiety symptoms and effects of sociodemographic variables before and after the first wave of COVID-19 in Qatar by Khaled, Salma M.

    Published 2022
    “…The data for 2020/21 showed a 35.1% and 29.2% decrease in depression and anxiety symptoms scores compared to pre-pandemic years (2017/2018) after adjusting for sociodemographic factors. …”
    Get full text
    Get full text
  6. 626
  7. 627

    Wind energy potential along the onshore and offshore Qatar by Mohammed, Aboobacker Valliyil

    Published 2020
    “…cant increase or decrease of wind power around Qatar in the last 40 years in most of the locations, while there is a slight decreasing trend in the o?…”
    Get full text
    Get full text
  8. 628

    Prevention of oral cancer by Malki, Ahmed Mohamed

    Published 2017
    “…In exploring the details within the chapter, one can conclude that oral cancer is a disease that is preventable and controllable but habitually has been given little significance due to many factors. …”
    Get full text
    Get full text
  9. 629
  10. 630
  11. 631
  12. 632
  13. 633
  14. 634
  15. 635
  16. 636
  17. 637

    Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus by Dimitrios, Patoulias

    Published 2023
    “…They have demonstrated1 that empagliflozin treatment resulted in a significant decrease in pulse pressure (PP), mean arterial pressure (MAP) and cardiac workload, compared with placebo; at week 12, placebo-adjusted mean changes from baseline were − 2.5 mmHg for PP, − 2.2 mmHg for MAP and − 315 mmHg x beats per minute (bpm) for cardiac workload (p < 0.0001 for all). …”
    Get full text
    Get full text
    Get full text
  18. 638
  19. 639
  20. 640